Connor, Clark & Lunn Investment Management (CC&L)’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.1M | Sell |
868,419
-61,225
| -7% | -$289K | 0.01% | 635 |
|
|
2025
Q1 | $4.27M | Buy |
929,644
+110,262
| +13% | +$506K | 0.02% | 536 |
|
|
2024
Q4 | $3.92M | Buy |
819,382
+38,449
| +5% | +$184K | 0.02% | 550 |
|
|
2024
Q3 | $3.66M | Buy |
780,933
+55,567
| +8% | +$261K | 0.02% | 514 |
|
|
2024
Q2 | $4.1M | Buy |
725,366
+32,488
| +5% | +$184K | 0.02% | 470 |
|
|
2024
Q1 | $2.85M | Buy |
692,878
+427,429
| +161% | +$1.76M | 0.01% | 576 |
|
|
2023
Q4 | $1.12M | Hold |
265,449
| – | – | 0.01% | 830 |
|
|
2023
Q3 | $1.15M | Hold |
265,449
| – | – | 0.01% | 779 |
|
|
2023
Q2 | $1.75M | Buy |
265,449
+41,299
| +18% | +$272K | 0.01% | 642 |
|
|
2023
Q1 | $1.52M | Buy |
224,150
+5,342
| +2% | +$36.3K | 0.01% | 620 |
|
|
2022
Q4 | $1.62M | Buy |
218,808
+99,878
| +84% | +$738K | 0.01% | 599 |
|
|
2022
Q3 | $1.18M | Buy |
118,930
+49,382
| +71% | +$488K | 0.01% | 618 |
|
|
2022
Q2 | $758K | Buy |
+69,548
| New | +$758K | ﹤0.01% | 682 |
|
|
2020
Q3 | – | Sell |
-42,341
| Closed | -$484K | – | 1135 |
|
|
2020
Q2 | $484K | Buy |
+42,341
| New | +$484K | ﹤0.01% | 762 |
|
|
2016
Q2 | – | Sell |
-25,300
| Closed | -$212K | – | 937 |
|
|
2016
Q1 | $212K | Sell |
25,300
-58,700
| -70% | -$492K | ﹤0.01% | 707 |
|
|
2015
Q4 | $782K | Sell |
84,000
-5,900
| -7% | -$54.9K | 0.01% | 478 |
|
|
2015
Q3 | $1.01M | Buy |
+89,900
| New | +$1.01M | 0.01% | 396 |
|
|
2015
Q2 | – | Sell |
-18,900
| Closed | -$176K | – | 662 |
|
|
2015
Q1 | $176K | Sell |
18,900
-17,000
| -47% | -$158K | ﹤0.01% | 513 |
|
|
2014
Q4 | $514K | Buy |
+35,900
| New | +$514K | ﹤0.01% | 387 |
|
|
2014
Q2 | – | Sell |
-144,707
| Closed | -$2.6M | – | 641 |
|
|
2014
Q1 | $2.6M | Buy |
144,707
+68,907
| +91% | +$1.24M | 0.02% | 243 |
|
|
2013
Q4 | $999K | Buy |
75,800
+7,600
| +11% | +$100K | 0.01% | 368 |
|
|
2013
Q3 | $768K | Buy |
68,200
+44,400
| +187% | +$500K | 0.01% | 300 |
|
|
2013
Q2 | $203K | Buy |
+23,800
| New | +$203K | ﹤0.01% | 471 |
|